Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SciSparc Ltd. (SPRC : NSDQ)

• Company Description    SciSparc Ltd. is a specialty clinical-stage pharmaceutical company. It focuses on the development of therapies to treat disorders of the central nervous system. The company's product pipeline includes SCI-110, SCI-160 and SCI-210. SciSparc Ltd. is based in TEL AVIV, Israel. Number of Employees: 3

• Price / Volume Information    Yesterday's Closing Price: $4.27 Daily Weekly Monthly 20 Day Moving Average: 44,682 shares Shares Outstanding: 0.57 (millions) Market Capitalization: $2.41 (millions) Beta: 2.71 52 Week High: $76.50 52 Week Low: $2.98 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -35.11% -38.28% 12 Week -19.04% -25.16% Year To Date -65.12% -68.46%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 20 RAUL WALLENBERG STREET TOWER A 2ND FLOOR - TEL AVIV,L3 6971916 ISR ph: 972-3717-5777 fax: - ir@scisparc.com http://www.scisparc.com

• General Corporate Information    Officers Oz Adler - Chief Executive Officer and Chief Financial Office Itschak Shrem - Chairman Amitay Weiss - President and Director Adi Zuloff-Shani - Chief Technologies Officer Amnon Ben Shay - Director Peer Information SciSparc Ltd. (GSAC) SciSparc Ltd. (CASIF) SciSparc Ltd. (ALCD.) SciSparc Ltd. (OMNN) SciSparc Ltd. (CGPI.) SciSparc Ltd. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: M82618139 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: 07/29/26 Share - Related Items Shares Outstanding: 0.57 Most Recent Split Date: 3.00 (0.11:1) Beta: 2.71 Market Capitalization: $2.41 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/29/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.33 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - - ROA 03/31/26 - - 12/31/25 - - 09/30/25 - - Current Ratio 03/31/26 - - 12/31/25 - 2.41 09/30/25 - - Quick Ratio 03/31/26 - - 12/31/25 - 2.38 09/30/25 - - Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - -1,467.76 09/30/25 - - Book Value 03/31/26 - - 12/31/25 - 12.93 09/30/25 - - Inventory Turnover 03/31/26 - - 12/31/25 - 1.97 09/30/25 - - Debt-to-Equity 03/31/26 - - 12/31/25 - 0.00 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - 0.00 09/30/25 - -

Powered by Zacks Investment Research ©